Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001193125-25-326263·GENMAB A/S
Schedule 13D ownership disclosure
MERUS N V
Common Shares, Euro 0.09 nominal value per share · CUSIP: N5749R100
Event date: 2025-12-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Genmab A/SReported CIK 0001434265
Shares: 71,946,801 · Class: 94.8%
- Genmab Holding II B.V.
Shares: 71,946,801 · Class: 94.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-326263
- Form type
- SCHEDULE 13D
- Filer
- GENMAB A/S
- CIK
- CIK 1434265
- Filed
- Dec 19, 2025
- Reporting period
- Dec 12, 2025
- Description
- Schedule 13D beneficial ownership